Author
Listed:
- Jie Zheng
(The Scripps Research Institute)
- Mi Ra Chang
(The Scripps Research Institute)
- Ryan E. Stites
(Eli Lilly and Company)
- Yong Wang
(Eli Lilly and Company)
- John B. Bruning
(The University of Adelaide, Institute for Photonics & Advanced Sensing (IPAS), School of Biological Sciences, University of Adelaide)
- Bruce D. Pascal
(The Scripps Research Institute)
- Scott J. Novick
(The Scripps Research Institute)
- Ruben D. Garcia-Ordonez
(The Scripps Research Institute)
- Keith R. Stayrook
(Eli Lilly and Company)
- Michael J. Chalmers
(Eli Lilly and Company)
- Jeffrey A. Dodge
(Eli Lilly and Company)
- Patrick R. Griffin
(The Scripps Research Institute)
Abstract
The vitamin D receptor/retinoid X receptor-α heterodimer (VDRRXRα) regulates bone mineralization via transcriptional control of osteocalcin (BGLAP) gene and is the receptor for 1α,25-dihydroxyvitamin D3 (1,25D3). However, supra-physiological levels of 1,25D3 activates the calcium-regulating gene TRPV6 leading to hypercalcemia. An approach to attenuate this adverse effect is to develop selective VDR modulators (VDRMs) that differentially activate BGLAP but not TRPV6. Here we present structural insight for the action of a VDRM compared with agonists by employing hydrogen/deuterium exchange. Agonist binding directs crosstalk between co-receptors upon DNA binding, stabilizing the activation function 2 (AF2) surfaces of both receptors driving steroid receptor co-activator-1 (SRC1) interaction. In contrast, AF2 of VDR within VDRM:BGLAP bound heterodimer is more vulnerable for large stabilization upon SRC1 interaction compared with VDRM:TRPV6 bound heterodimer. These results reveal that the combination of ligand structure and DNA sequence tailor the transcriptional activity of VDR toward specific target genes.
Suggested Citation
Jie Zheng & Mi Ra Chang & Ryan E. Stites & Yong Wang & John B. Bruning & Bruce D. Pascal & Scott J. Novick & Ruben D. Garcia-Ordonez & Keith R. Stayrook & Michael J. Chalmers & Jeffrey A. Dodge & Patr, 2017.
"HDX reveals the conformational dynamics of DNA sequence specific VDR co-activator interactions,"
Nature Communications, Nature, vol. 8(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00978-7
DOI: 10.1038/s41467-017-00978-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00978-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.